We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Syneos Health Inc | NASDAQ:SYNH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 42.98 | 42.96 | 42.99 | 0 | 01:00:00 |
“I am thrilled to see Jennifer Sozio and Caitlin Purinai recognized by the HBA for their outstanding performance and commitment to excellence,” said Michelle Keefe, CEO, Syneos Health. “Jennifer and Caitlin are role models for employees across the organization, representing women in healthcare who continuously deliver outstanding performance, demonstrate inclusive leadership, and are completely committed to customers, colleagues and the communities where we work and live. I’m honored to see this recognition by our long-standing HBA partner – demonstrating our shared alignment to empowering women worldwide.”
HBA is a global nonprofit organization comprised of individuals and organizations spanning the healthcare industry, committed to furthering the advancement and impact of women. Each year, the organization celebrates women leaders across the life sciences spectrum through their Corporate Partner employee recognition program.
In 2023, two Syneos Health female leaders are being recognized by the HBA in its Luminary Award and Rising Stars Award categories. Nominated by the HBA’s Corporate Partners, the Luminary Award recognizes women who serve as a role model in their company, actively mentoring and sponsoring others, and advancing other women’s careers through their dedication to the healthcare industry. The Rising Stars Award represents women in various career stages and disciplines who have demonstrated noteworthy achievements and proven attention to furthering their careers.
Syneos Health has been a member of the HBA for more than 20 years. This commitment is part of the organization’s DE&I focus, investing in women’s leadership, innovation and creativity across the biopharmaceutical sector.
“We value our HBA relationship and the customer conversations we host every day. Together, we are committed to changing patients’ lives by Shortening the distance from lab to life®.”
About Syneos HealthSyneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact: | Press/Media Contact: |
Ronnie Speight | Gary Gatyas |
Senior Vice President, Investor Relations | Executive Director, External Communications |
+1 919 745 2745 | +1 908 763 3428 |
Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
1 Year Syneos Health Chart |
1 Month Syneos Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions